Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Prostatic Neoplasms 1Lymphoma, AIDS-Related 1Lymphoma 1HIV Infections 1Acquired Immunodeficiency Syndrome 1

Interventions

Etoposide 9Rituximab 8Cyclophosphamide 7Vincristine 6Prednisone 6Doxorubicin 5Filgrastim 4Cytarabine 3Radiotherapy 2Procarbazine 2Peripheral Blood Stem Cell Transplantation 2Melphalan 2Lomustine 2Carmustine 2prednylidene 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1liposomal doxorubicin 1ibrutinib 1ibritumomab tiuxetan 1etoposide phosphate 1efavirenz 1deltacortene 1VAP-cyclo protocol 1Ultrasonography 1Radioimmunotherapy 1Ondansetron 1O(6)-benzylguanine 1Mitoguazone 1Methylprednisolone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Lymphoma, AIDS-Related × Genes × Clear all
NCT00858793 2022-09-08

High-dose Chemotherapy With Transplantation of Gene-modified Haematopoietic Stem Cells for HIV-positive Patients With Malignant Diseases Indicating an HSCT

Universitätsklinikum Hamburg-Eppendorf

Phase 1/2 Terminated
5 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, HIV Infections, Lymphoma, AIDS-Related

Data powered by HemOnc (CC BY 4.0) Colophon âš¡